Additional Details
-
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Hannibal Regional HospitalHannibal MO. 63401View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Coastal Pulmonary & Critical Care, PLCSt. Petersburg FL. 33704-2733View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Palmtree Clinical ResearchPalm Springs CA. 92262View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Paradigm Clinical Research Centers, Inc. - ReddingRedding CA. 96001View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Anmed Medical CenterAnderson SC. 29621View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research Associates of Central, PA, LLCDuBois PA. 15801View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Horizon Clinical Research GroupCypress TX. 77429View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Pulmonary Specialists of The Palm BeachesLoxahatchee Groves FL. 33470View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research of Gastonia (CRG)Gastonia NC. 28054View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Elevate Clinical ResearchHouston TX. 77058View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
El Paso Pulmonary Association, PAEl Paso TX. 79902View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research and Associates, Inc.Miami FL. 33126View Details -
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Massachusetts General HospitalBoston MA. 02114View Details -
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
National Institutes of Health Clinical CenterBethesda MD. 20892View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Cleveland Clinic FloridaWeston FL. 33331View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Essence MD ResearchNaples FL. 34102View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
UT Health San AntonioSan Antonio TX. 78229View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Yale University School of MedicineNew Haven CT. 06520View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Temple UniversityPhiladelphia PA. 19140View Details -
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)Québec G1V 4G5View Details